Alternative Data for DaVita
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3,000 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 922,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,457 | Sign up | Sign up | Sign up |
| Facebook Followers | 125,156 | Sign up | Sign up | Sign up |
| Instagram Followers | 27,473 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 15 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,231 | Sign up | Sign up | Sign up |
| X Followers | 14,474 | Sign up | Sign up | Sign up |
| X Mentions | 2 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 46,600 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 38,805 | Sign up | Sign up | Sign up |
About DaVita
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
| Price | $105.61 |
| Target Price | Sign up |
| Volume | 750,150 |
| Market Cap | $7.73B |
| Year Range | $103.87 - $151.32 |
| Dividend Yield | 0% |
| PE Ratio | 11.16 |
| Analyst Rating | 0% buy |
| Earnings Date | February 2 '26 |
| Industry | Medical Care Facilities |
In the news
 |
Assessing DaVita (DVA) Valuation As Earnings Growth Optimism Builds Ahead Of Quarterly ResultsJanuary 25 - Yahoo |
|
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to KnowJanuary 21 - Yahoo |
|
DaVita Inc. Schedules 4th Quarter 2025 Investor Conference CallJanuary 20 - Yahoo |
|
Here's Why You Should Hold DaVita Stock in Your Portfolio for NowJanuary 19 - Yahoo |
|
Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain?January 16 - Yahoo |
|
Is DaVita’s (DVA) Community Health Push Reframing Its Balance Between Patient Impact and Profitability?January 16 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 3.42B | 2.33B | 1.09B | 150M | 486M | 2.510 |
| Q2 '25 | 3.38B | 2.26B | 1.12B | 199M | 690M | 2.950 |
| Q1 '25 | 3.22B | 2.24B | 984M | 163M | 598M | 2.000 |
| Q4 '24 | 3.29B | 2.23B | 1.07B | 259M | 727M | 2.240 |
| Q3 '24 | 3.26B | 2.15B | 1.11B | 215M | 695M | 2.590 |
Insider Transactions View All
| BUFFETT WARREN E filed to sell 31,759,065 shares at $135.4. October 29 '25 |
| BUFFETT WARREN E filed to sell 32,160,579 shares at $140.6. August 4 '25 |
| HEARTY JAMES O filed to sell 26,038 shares at $150. July 24 '25 |
| BUFFETT WARREN E filed to sell 33,808,519 shares at $139.6. May 27 '25 |
| BUFFETT WARREN E filed to sell 33,796,541 shares at $140.2. May 27 '25 |
Similar companies
Read more about DaVita (DVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - DaVita
The Market Cap of DaVita is $7.73B.
As of today, DaVita's PE (Price to Earnings) ratio is 11.16.
DaVita will report its next earnings on February 2 '26.
Currently, the price of one share of DaVita stock is $105.61.
The DVA stock price chart above provides a comprehensive visual representation of DaVita's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DaVita shares. Our platform offers an up-to-date DVA stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, DaVita (DVA) does not offer dividends to its shareholders. Investors interested in DaVita should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of DaVita are Encompass Health, Brookdale Senior Living, Amedisys, Tenet Healthcare, and Nutex Health.
